Checked.be · Company dossierhttps://checked.be/en/c/trimephar-0807210244 · as of 04-11-2026
TRIMEPHAR
Active
Private limited company · founded 2008 · active for 18 yearsRue de la Champignotte(AIN) 13, 4317 Faimes, BelgiumKBO/BCE: BE 0807.210.244
Summary
TRIMEPHAR has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €777,347 and a net result of €166,856. Equity has been stable since 2018 (±1.6% per year). Its solvency ranks better than 73% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Score breakdownlowers riskEquity €777,347 (60.0% of total assets)Founded in 2008Size: 3.6 FTE, total assets €1.3mFigures for financial year 2025 (filed on 17-06-2026)Show the evidence
Checked score
Score 2025
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
95/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 60% of micro companies in retail trade (NACE 47)
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
Strong
Solvency85-1
equity 60.0% of total assets
Liquidity49+3
short-term debt 40.0% · cash 14.5%
Profitability85-2
return on assets 12.9%
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
0.1%Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months12-2024: 0.1%01-2025: 0.1%● unchanged vs 12-202402-2025: 0.1%● unchanged vs 01-202503-2025: 0.1%● unchanged vs 02-202504-2025: 0.1%● unchanged vs 03-202505-2025: 0.1%● unchanged vs 04-202506-2025: 0.1%● unchanged vs 05-202507-2025: 0.1%● unchanged vs 06-202508-2025: 0.1%● unchanged vs 07-202509-2025: 0.1%● unchanged vs 08-202510-2025: 0.1%● unchanged vs 09-202511-2025: 0.1%● unchanged vs 10-202512-2025: 0.1%● unchanged vs 11-202501-2026: 0.1%● unchanged vs 12-202502-2026: 0.1%● unchanged vs 01-202603-2026: 0.1%● unchanged vs 02-202604-2026: 0.1%● unchanged vs 03-202605-2026: 0.1%● unchanged vs 04-202606-2026: 0.1%● unchanged vs 05-2026highest value07-2026: 0.1%● unchanged vs 06-2026lowest value08-2026: 0.1%● unchanged vs 07-2026lowest value09-2026: 0.1%● unchanged vs 08-2026lowest value10-2026: 0.1%● unchanged vs 09-2026lowest value11-2026: 0.1%● unchanged vs 10-2026lowest value
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.0 (0.99 in 2024), below the usual 1.5. Short-term debt is 40% and cash 14.5% of total assets. 40% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
75-100
Excellent
under 0.55%
60-74
Healthy
0.55% to 1.5%
45-59
Fair
1.5% to 4.2%
25-44
Weak
4.2% to 15.0%
0-24
Critical
over 15.0%
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 73% of them on solvency, 50% on liquidity, 79% on profitability and 37% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 15 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 5 accounts filed within 31 days either side of that date).
The EBIT margin is the share of each euro of revenue left from ordinary operations. The higher it is, the more room the company has to absorb a setback.
The net result is what is left after all costs and taxes. One loss year is not an alarm on its own. After several loss years in a row, it pays to find out why.
Working capital is what is left when the company pays its short-term debts with its short-term assets. Positive means it can pay its bills in the short term.
Net result€0.2m-€0.2m▼ 2.1%€0.2mabove the sector's middle half▼ 13.0%€0.2mabove the sector's middle half▲ 1.6%€0.2mabove the sector's middle half▲ 10.9%€0.2mabove the sector's middle half▼ 4.1%€0.2mabove the sector's middle half▲ 4.7%€0.2mabove the sector's middle half▼ 13.2%
Equity€0.9m-€1.1m▲ 22.6%€0.8mabove the sector's middle half▼ 21.7%€0.8mabove the sector's middle half▼ 9.3%€0.8mwithin the sector's middle half▲ 1.5%€0.8mwithin the sector's middle half▲ 0.5%€0.8mwithin the sector's middle half▲ 1.6%€0.8mabove the sector's middle half▼ 0.4%
Total assets€1.3m-€1.4m▲ 7.9%€2.0mabove the sector's middle half▲ 49.8%€1.7mwithin the sector's middle half▼ 15.1%€1.4mwithin the sector's middle half▼ 20.5%€1.4mwithin the sector's middle half▲ 2.5%€1.3mwithin the sector's middle half▼ 9.0%€1.3mwithin the sector's middle half▲ 0.5%
Working capital€0.8m-€1.0m▲ 32.6%-€0.1mbelow the sector's middle half-€0.2mbelow the sector's middle half▼ 10.8%-€0.1mbelow the sector's middle half▲ 32.5%-€0.06mbelow the sector's middle half▲ 43.9%-€0.003mwithin the sector's middle half▲ 94.9%€0.002mwithin the sector's middle half
Solvency68.3%-77.6%▲ 9.3pp40.6%within the sector's middle half▼ 37.1pp43.4%within the sector's middle half▲ 2.8pp55.4%above the sector's middle half▲ 12.0pp54.2%within the sector's middle half▼ 1.1pp60.5%above the sector's middle half▲ 6.3pp60.0%within the sector's middle half▼ 0.6pp
Current ratio5.74-6.33▲ 0.590.87below the sector's middle half▼ 5.450.83below the sector's middle half▼ 0.050.81below the sector's middle half▼ 0.010.90below the sector's middle half▲ 0.090.99within the sector's middle half▲ 0.091.00within the sector's middle half▲ 0.01
Return on assets (ROA)15.7%-14.3%▼ 1.5pp8.3%within the sector's middle half▼ 6.0pp9.9%within the sector's middle half▲ 1.6pp13.9%above the sector's middle half▲ 3.9pp13.0%above the sector's middle half▼ 0.9pp14.9%above the sector's middle half▲ 1.9pp12.9%above the sector's middle half▼ 2.0pp
Staff (FTE)2.1-2.2▲ 4.8%3.1within the sector's middle half▲ 40.9%4within the sector's middle half▲ 29.0%4.3within the sector's middle half▲ 7.5%4.2within the sector's middle half▼ 2.3%4.2within the sector's middle half=3.6within the sector's middle half▼ 14.3%
abovewithinbelowThe sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 13% lower than in 2024 and the lowest since 2021.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.3m
59.8%
40.2%
Fixed assets€775,189 ▼ 1.7%
Current assets€521,126 ▲ 4.1%
Equity and liabilities €1.3m
60.0%
40.0%
Equity€777,347 ▼ 0.4%
Debt€518,968 ▲ 1.9%
Debt's share of the balance-sheet total rises from 39.5% to 40.0%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€290,641▼
2024 · €325,347
Cash flow
€232,285▼
2024 · €257,967
Quick ratio
0.63▲
2024 · 0.57
Debt to equity
0.67▲
2024 · 0.65
ROE
21.5%▼
2024 · 24.6%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€518,967▲
2024 · €503,739
Income taxes
€56,495▼
2024 · €64,685
Staff costs
€235,623▲
2024 · €230,057
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Staff
social balance sheet
Item
31-12-2021
31-12-2022
31-12-2023
31-12-2024
31-12-2025
Employees at the balance-sheet date
5
5
5
5
5
full-time
2
2
2
2
2
part-time
3
3
3
3
3
in full-time equivalents
4.2
4
4.1
4
3.5
Average over the year, in full-time equivalents
4
4.3
4.2
4.2
3.6
On a permanent contract
5
5
5
5
5
Joined
1
2
3
1
1
Left
0
2
3
1
1
Training hours
-
-
-
-
41
Source: social balance sheet in the 2021 to 2025 annual accounts
Investments
fixed assets acquired
Item
2021
2022
2023
2024
2025
Tangible fixed assets
€146,903
-
-
€760
€417,956
Depreciation and write-downs of the year
€70,881
€70,504
€69,703
€65,833
€65,429
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
Filed annual accountsAs filed with the NBB · 2025 against 2024 · 55 lines
Balance sheetCode20242025
Assets
Total assets20/58€1.3m€1.3m▲
Fixed assets21/28€0.8m€0.8m▼
Tangible fixed assets22/27€0.8m€0.8m▼
Land and buildings22€0.8m€0.7m▼
Plant, machinery and equipment23€0.009m€0.005m▼
Furniture and vehicles24€0.001m€0.001m▼
Assets under construction and advance payments27-€0.05m
Current assets29/58€0.5m€0.5m▲
Stocks and contracts in progress3€0.2m€0.2m▼
Stocks30/36€0.2m€0.2m▼
Amounts receivable within one year40/41€0.1m€0.1m▼
Trade receivables40€0.1m€0.1m▼
Other amounts receivable41€0.001m€0.007m▲
Cash at bank and in hand54/58€0.1m€0.2m▲
Deferred charges and accrued income490/1€0.004m€0.004m▼
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.3m▲
Equity10/15€0.8m€0.8m▼
Contributions10/11€0.1m€0.1m=
Reserves13€0.7m€0.7m=
Non-distributable reserves130/1€0.001m€0.001m=
Reserves not available under the articles1311€0.001m€0.001m=
Distributable reserves133€0.7m€0.7m=
Profit (loss) carried forward14€0.004m€0.001m▼
Amounts payable17/49€0.5m€0.5m▲
Amounts payable after more than one year17€0.005m-
Financial debts170/4€0.005m-
Amounts payable within one year42/48€0.5m€0.5m▲
Current portion of amounts payable after more than one year42€0.02m€0.005m▼
Trade debts44€0.1m€0.1m▼
Suppliers440/4€0.1m€0.1m▼
Taxes, remuneration and social security45€0.04m€0.04m▼
Taxes450/3€0.005m€0.003m▼
Remuneration and social security454/9€0.04m€0.03m▼
Other amounts payable47/48€0.3m€0.4m▲
Accrued charges and deferred income492/3€0€0▲
Income statementCode20242025
Remuneration, social security and pensions62€0.2m€0.2m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.07m€0.07m▼
Other operating charges640/8€0.002m€0.002m▲
Gross operating margin9900€0.6m€0.5m▼
Operating profit (loss)9901€0.3m€0.2m▼
Financial income75/76B€409€321▼
Recurring financial income75€409€321▼
Financial charges65/66B€0.003m€0.002m▼
Recurring financial charges65€0.003m€0.002m▼
Profit (loss) for the period before taxes9903€0.3m€0.2m▼
Income taxes67/77€0.06m€0.06m▼
Profit (loss) for the period9904€0.2m€0.2m▼
Profit (loss) for the period to be appropriated9905€0.2m€0.2m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.3m€0.2m▼
Profit (loss) brought forward from the previous period14P€0.07m€0.004m▼
Transfer to equity691/2€0.08m-
To other reserves6921€0.08m-
Profit to be distributed694/7€0.2m€0.2m▼
Return on contributions (dividend)694€0.2m€0.2m▼
Social balance sheet
Average headcount (FTE)90874.23.6▼
The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
The figures are counted, not predicted. They describe the group, not TRIMEPHAR.
In July 2024, 34,693 companies had the same profile as TRIMEPHAR has now. Two years later, 95.3% were still going and 0.7% had gone bankrupt.
Micro
10 to 20 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
95.3%was still going
3.9%stopped otherwise
0.7%went bankrupt
That fits the bankruptcy probability of TRIMEPHAR itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
3.0%
3.1%
10
5.6%
6.2%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for TRIMEPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Director (not named in the articles) · in office according to the act of 24-01-2024 · term without a fixed end · Public limited company · permanent representative: OLIVIER François-Xavier Willy Ghislain · listed in the 2025 annual accounts, filed on 17-06-2026
Current
Permanent representatives 1
FW
OLIVIER François-Xavier Willy Ghislain
Permanent representative · in office according to the act of 24-01-2024 · for PHARMACIE LEJEUNE
Permanent representative: OLIVIER François-Xavier Willy Ghislain · Purpose change · Amendment of the articles16 points ▸
General meeting, 19-12-2023
Other provision, “rapport organe d'administration justifiant modification objet, prend acte,non annexé au procès-verbal,déposé en original au greffe du tribunal de l'entreprise a…” (deed in French)
Purpose change
Other provision, “mise en concordance statuts avec résolution objet, reporter établissement définitif texte modifications consécutives dans cadre résolution point III(refonte)” (deed in French)
Other provision, “mise en concordance statuts avec résolution assemblée générale ordinaire, reporter établissement définitif texte modifications consécutives dans cadre résolutio…” (deed in French)
Other provision, “refonte statuts pour homogénéité avec statuts autres sociétés similaires détenues par actionnaire unique, refondre” (deed in French)
Amendment of the articles
Capital
Other provision, “Article 6 Appels de fonds” (deed in French)
Other provision, “Article 8 Apport en numéraire avec émission de nouvelles actions – Droit de préférence” (deed in French)
Director reappointment, PHARMACIE LEJEUNE (director (not named in the articles))
Other provision, “administrateur, représentation pour désignation du représentant permanent” (deed in French), mentioned 2 times in the deed
Each sentence rests on a document from the KBO register, the Belgian Official Gazette or the National Bank. The number after the sentence opens that document.
On 20 October 2008, TRIMEPHAR was incorporated.1Total assets went from €1.3m in 2018 to €1.3m in 2025 and headcount from 2.1 to 3.6 full-time equivalents.2
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région wallonne, par simple décision organe d'administration en tout endroit de cette région ou région de langue française de Belgique,sans…”
L'achat,la vente,la fabrication,la représentation,l'importation,l'exportation,l'agence,le courtage,la commission,la consignation,l'exploitation et en général toutes activités commerciales relatives aux médicaments,produits chimiques,pharmaceutiques,médicaux et vétérinaires,de toutes sortes et de tous autres produits du même ordre présents et futurs
Le commerce de plantes médicinales,de produits de droguerie,de parfumerie,de beauté,de toilette,de laboratoires,de bandagisterie,orthopédiques,diététiques,d'optique,de vision,auditifs,ménagers et de produits ou services y afférents
La pratique des analyses industrielles et cliniques
Les recherches et les analyses au sens le plus large des mots
Les recherches cliniques biologiques et analyses biologiques
Le bureau d'intérim de personnel pour pharmacies et laboratoires cliniques
La mise à disposition de personnel aux tiers
Le traitement,l'automatisation,l'étude et la programmation sur ordinateur
La vaccination et actes médicaux permis par la loi
Toute activité commerciale se rapportant à l'hygiène publique au sens le plus large du terme
Tous services,plus spécifiquement dans le secteur de la santé